Department of Diagnostic and Interventional Radiology, University of Heidelberg, Germany. Boris
Eur J Radiol. 2010 Jul;75(1):e57-63. doi: 10.1016/j.ejrad.2009.07.013. Epub 2009 Aug 18.
Purpose of this study was to evaluate the frequency, probability, and factors associated with expulsion of submucosal fibroids after uterine artery embolization (UAE) in addition to the technical and clinical results at 1-year follow-up.
We determined the preinterventional volume of each dominant submucosal fibroid using the commonly used ellipsoid formula and a 3D volumetry in the MRI to define a threshold value in milliliters that indicates the probability for a fibroid expulsion. Assessment of fibroid expulsion was done by MRI at 3-month intervals for a year. Assessment of clinical mid term success was achieved by applying questionnaires at 1-year follow-up.
Technical success was observed in all 20 patients (mean age of 41.4+/-5.6 years; range: 29.2-51.1 years). Two (10%) minor and one (5%) major complications occurred. 10/20 dominant submucosal fibroids were completely expelled during the follow-up. Using 3D MRI volumetry the preinterventional mean volume of the later expelled fibroids was 56.8+/-57.0 ml (range 2.3-198.0 ml) and the mean volume of non-expelled fibroids was 123.8+/-147.3 ml (range 24.0-531.8 ml). This difference was statistically significant, but weak (p=0.0494). Fibroids with a volume equal or less than the threshold value (66.0 ml) were 73% likely to be expelled and fibroids larger than 66.0 ml were 78% likely not to be expelled. All 20 patients demonstrated a significant reduction in the fibroid related symptoms.
In our study the complication rate was low despite increased rates of fibroid expulsion (50%); simultaneously the rate of treatment satisfaction was very high. Patients with a dominant submucosal fibroid under 66.0 ml should be informed about the probability of fibroid expulsion and the accompanying symptoms.
本研究旨在评估子宫动脉栓塞术(UAE)后黏膜下肌瘤排出的频率、概率和相关因素,并在 1 年随访时评估其技术和临床结果。
我们使用常用的椭圆公式和 MRI 中的 3D 体积测量来确定每个主要黏膜下肌瘤的预介入体积,并定义一个以毫升为单位的阈值,该值表示肌瘤排出的概率。在 1 年内每 3 个月进行 MRI 评估以确定肌瘤排出情况。通过在 1 年随访时应用问卷调查评估中期临床疗效。
20 例患者均获得技术成功(平均年龄 41.4+/-5.6 岁;范围:29.2-51.1 岁)。发生 2 例(10%)轻微并发症和 1 例(5%)严重并发症。在随访期间,20 个主要黏膜下肌瘤中有 10 个完全排出。使用 3D MRI 体积测量,后来排出的肌瘤的预介入平均体积为 56.8+/-57.0ml(范围 2.3-198.0ml),未排出的肌瘤平均体积为 123.8+/-147.3ml(范围 24.0-531.8ml)。这一差异具有统计学意义,但较弱(p=0.0494)。体积等于或小于阈值(66.0ml)的肌瘤有 73%的可能性排出,体积大于 66.0ml 的肌瘤有 78%的可能性不排出。所有 20 例患者的肌瘤相关症状均显著减轻。
尽管肌瘤排出率(50%)较高,但在我们的研究中,并发症发生率仍较低;同时,治疗满意度非常高。对于体积小于 66.0ml 的主要黏膜下肌瘤患者,应告知其肌瘤排出的概率和伴随症状。